425 related articles for article (PubMed ID: 21649882)
1. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F
Crit Care; 2011; 15(3):R137. PubMed ID: 21649882
[TBL] [Abstract][Full Text] [Related]
2. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Hites M; Taccone FS; Wolff F; Cotton F; Beumier M; De Backer D; Roisin S; Lorent S; Surin R; Seyler L; Vincent JL; Jacobs F
Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743
[TBL] [Abstract][Full Text] [Related]
4. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
Delattre IK; Hites M; Laterre PF; Dugernier T; Spapen H; Wallemacq PE; Jacobs F; Taccone FS
Int J Antimicrob Agents; 2020 Oct; 56(4):106113. PubMed ID: 32721604
[TBL] [Abstract][Full Text] [Related]
5. β-lactam antibiotic concentrations during continuous renal replacement therapy.
Beumier M; Casu GS; Hites M; Seyler L; Cotton F; Vincent JL; Jacobs F; Taccone FS
Crit Care; 2014 May; 18(3):R105. PubMed ID: 24886826
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I
Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938
[TBL] [Abstract][Full Text] [Related]
7. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
Lheureux O; Trepo E; Hites M; Cotton F; Wolff F; Surin R; Creteur J; Vincent JL; Gustot T; Jacobs F; Taccone FS
Liver Int; 2016 Jul; 36(7):1002-10. PubMed ID: 26645828
[TBL] [Abstract][Full Text] [Related]
8. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
[TBL] [Abstract][Full Text] [Related]
9. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Paul M; Yahav D; Bivas A; Fraser A; Leibovici L
Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD005197. PubMed ID: 21069685
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Dosing in Continuous Renal Replacement Therapy.
Shaw AR; Mueller BA
Adv Chronic Kidney Dis; 2017 Jul; 24(4):219-227. PubMed ID: 28778361
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira J; Póvoa P
Crit Care; 2011; 15(5):R206. PubMed ID: 21914174
[TBL] [Abstract][Full Text] [Related]
12. Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
Plüss-Suard C; Pannatier A; Ruffieux C; Kronenberg A; Mühlemann K; Zanetti G
Antimicrob Agents Chemother; 2012 Feb; 56(2):989-94. PubMed ID: 22123703
[TBL] [Abstract][Full Text] [Related]
13. Single β-lactams versus combinations as empiric therapy for infections with
Almarzoky Abuhussain SS; Sutherland CA; Nicolau DP
Infect Dis (Lond); 2020 Jan; 52(1):33-38. PubMed ID: 31595829
[No Abstract] [Full Text] [Related]
14.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
15. Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients.
Beumier M; Casu GS; Hites M; Wolff F; Cotton F; Vincent JL; Jacobs F; Taccone FS
Minerva Anestesiol; 2015 May; 81(5):497-506. PubMed ID: 25220556
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.
Awissi DK; Beauchamp A; Hébert E; Lavigne V; Munoz DL; Lebrun G; Savoie M; Fagnan M; Amyot J; Tétreault N; Robitaille R; Varin F; Lavallée C; Pichette V; Leblanc M
Pharmacotherapy; 2015 Jun; 35(6):600-7. PubMed ID: 26095008
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?
Öbrink-Hansen K; Juul RV; Storgaard M; Thomsen MK; Hardlei TF; Brock B; Kreilgaard M; Gjedsted J
Antimicrob Agents Chemother; 2015 Nov; 59(11):7018-26. PubMed ID: 26349823
[TBL] [Abstract][Full Text] [Related]
18. Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
Kays MB
Pharmacotherapy; 1999 Dec; 19(12):1392-9. PubMed ID: 10600088
[TBL] [Abstract][Full Text] [Related]
19. Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.
Jung B; Mahul M; Breilh D; Legeron R; Signe J; Jean-Pierre H; Uhlemann AC; Molinari N; Jaber S
Crit Care Med; 2017 May; 45(5):e470-e478. PubMed ID: 28240688
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]